Terms: = Ovarian cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
11 results:
1. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and ovarian cancer, Cologne.
Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
[TBL] [Abstract] [Full Text] [Related]
2. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.
Solsky I; Chen J; Rebbeck TR
Gynecol Oncol; 2020 Feb; 156(2):363-376. PubMed ID: 31918993
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasonographically diagnosed dermoid cysts do not influence ovarian stimulation response in an
Rodriguez-Purata J; Gonzalez-Foruria I; Montoya-Botero P; Rodriguez I; Hereter L; Polyzos NP; Graupera B; Martínez F; Pascual MA; Coroleu B
Gynecol Endocrinol; 2019 Jul; 35(7):612-617. PubMed ID: 30727778
[TBL] [Abstract] [Full Text] [Related]
4. One case report of giant atypical leiomyoma of the ovary.
Wang QM; Zhao Y; Ma Y; Yao LT; Han X
Medicine (Baltimore); 2018 Oct; 97(40):e12526. PubMed ID: 30290610
[TBL] [Abstract] [Full Text] [Related]
5. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
[TBL] [Abstract] [Full Text] [Related]
6. ovarian Function, Not Age, Predicts the Benefit from ovarian Suppression or Ablation for Premenopausal Women with Breast cancer.
Xue C; Peng R; Cao Y; Wang S; Shi Y; An X; Xu F; Yuan Z
PLoS One; 2016; 11(2):e0148849. PubMed ID: 26866810
[TBL] [Abstract] [Full Text] [Related]
7. Pyrosequencing-Based Assays for Rapid Detection of HER2 and her3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting her3 in Retroperitoneal Leiomyosarcoma.
González-Alonso P; Chamizo C; Moreno V; Madoz-Gúrpide J; Carvajal N; Daoud L; Zazo S; Martín-Aparicio E; Cristóbal I; Rincón R; García-Foncillas J; Rojo F
Int J Mol Sci; 2015 Aug; 16(8):19447-57. PubMed ID: 26287187
[TBL] [Abstract] [Full Text] [Related]
8. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
[TBL] [Abstract] [Full Text] [Related]
9. ovarian tumors metastasize in blood.
Cancer Discov; 2014 Sep; 4(9):OF2. PubMed ID: 25185201
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
[TBL] [Abstract] [Full Text] [Related]
11. c-erbb-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract] [Full Text] [Related]